ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
会议论文

Osemitamab plus capecitabine and oxaliplatin (CAPOX) as the first-line treatment of advanced G/GEJ cancer - updated efficacy data per claudin 18.2 expression level from study TranStar102/TST001-1002-cohort C

Shen, L.; Liu, D.; Li, N.; Guo, W.; Liu, T.; Li, H.; Li, J.; Zhao, F.; Sun, M.; Bai, Y.; Deng, Y.; Zhuang, Z.; Fan, Q.; Han, L.; Xia, S.; Zhu, X.; Qi, C.; Xu, L.; Qian, X.; Germa, C.复旦大学; 哈尔滨医科大学; 郑州大学; 苏州大学; 厦门大学; 中山大学; 6; 1
2023-6DOI: 10.1016/j.annonc.2023.04.034
4阅读
引用收藏
分享
相关
加载中…
  • Osemitamab in combination with capecitabine and oxaliplatin (CAPOX) as a first line treatment of advanced G/GEJ cancer: Updated data of cohort C from a phase I/IIa, multi-center study (TranStar102/TST001-1002)
    Shen, Lin; Liu, Dan; Li, Ning; Guo, Weijian; Liu, Tianshu; Li, Hongli; Li, Jiayi; Bai, Yuxian; Deng, Yanhong; Zhuang, Zhi-xiang; Sun, Meili; Fan, Qingxia; Zhao, Fuyou; Han, Liang; Xia, Zhenzhong; Wang, Jianming; Qi, Charlie; Xu, Li; Qian, Xueming; Germa, CarolineAnnual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Chicago, IL, 2023-06-02 To 2023-06-06.
  • A phase 1 trial of claudin 18.2-specific antibody-drug conjugate CMG901 in patients with advanced gastric/gastroesophageal junction cancer.
    Xu, Rui-Hua; Ruan, Dan-Yun; Zhang, Dong-Sheng; Liu, Fu-Rong; Luo, Su-Xia; Zhuang, Zhi-Xiang; Wang, Zhen-Ning; Liu, Fu-Nan; Zhang, Yan-Qiao; Yang, Jian-Wei; Chen, Zhen-Dong; Wang, Yong-Sheng; Wang, Jun-Ye; Liang, Xiao-Hua; Wu, Xiao-Jie; Zheng, Yu-Long; Liu, Jian; Shi, Xi; Liu, Wei; Chen, BoAnnual Meeting of the American-Society-of-Clinical-Oncology (ASCO), ELECTR NETWORK, 2023-11 To 2023-11.
  • KEYNOTE-859 study of pembrolizumab plus chemotherapy for advanced HER2-negative gastric or gastroesophageal junction (G/GEJ) cancer: Outcomes in the protocol-specified PD-L1-selected populations
    Rha, Sun Young; Wyrwicz, Lucjan; Weber, Patricio Eduardo Yanez; Bai, Yuxian; Ryu, Min-Hee; Lee, Jeeyun; Rivera, Fernando; Alves, Gustavo Vasconcelos; Garrido, Marcelo; Shiu, Kai-Keen; Fernandez, Manuel Gonzalez; Li, Jin; Lowery, Maeve Aine; Cil, Timucin; Cruz, Felipe Melo; Qin, Shukui; Yin, Lina; Bordia, Sonal; Bhagia, Pooja; Oh, Do-YounAnnual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Chicago, IL, 2023-06-02 To 2023-06-06.被引 4
查看全部 →

会议信息

论文集名
ANNALS OF ONCOLOGY
发表日期
2023-06
起止页码
S3-S3
DOI
10.1016/j.annonc.2023.04.034
资助标注
Suzhou Transcenta Therapeutics Co., Ltd.
收录
SCIE

作者

  • S

    Shen, L. (第一作者)

    peking univ canc hosp & inst

  • L

    Liu, D.

    peking univ canc hosp & inst

查看全部 20 位作者收起作者
  • L

    Li, N.

    zhengzhou univ

  • G

    Guo, W.

    fudan univ

  • L

    Liu, T.

    fudan univ

  • L

    Li, H.

  • L

    Li, J.

    1 · xiamen univ

  • Z

    Zhao, F.

    1 · bengbu med coll

  • S

    Sun, M.

    jinan cent hosp

  • B

    Bai, Y.

    harbin med univ

  • D

    Deng, Y.

    6 · sun yat sen univ

  • Z

    Zhuang, Z.

    2 · soochow univ

  • F

    Fan, Q.

    1 · zhengzhou univ

  • H

    Han, L.

  • X

    Xia, S.

  • Z

    Zhu, X.

  • Q

    Qi, C.

  • X

    Xu, L.

  • Q

    Qian, X.

  • G

    Germa, C.

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417